Keywords: Eli Lilly, USA, Innovation, Research, Challenges

Lilly CEO Lechleiter calls for repair of the “engine of biopharma innovation”

Article | 02 November 2009

Print This

John Lechleiter, chairman and chief executive of US drug major Eli Lilly said that the engine of biopharmaceutical innovation is " ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in